A Multi-Analyte cfDNA-based Blood Test for Early Detection of Hepatocellular Carcinoma
Listen to this summary
The authors aimed to evaluate the performance of the HelioLiver Dx blood test for the early detection of hepatocellular carcinoma (HCC) in high-risk patients with cirrhosis, comparing its sensitivity and specificity to that of abdominal ultrasound. In a multicenter validation study involving 1,268 participants, the HelioLiver Dx test demonstrated superior sensitivity for detecting HCC lesions, particularly small ones, while maintaining non-inferior specificity compared to ultrasound. This study highlights the potential of a more accessible blood-based test to enhance early HCC detection and improve clinical outcomes for at-risk populations.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Journal of hepatology
View all →May 4, 2026 · Journal of hepatology
CD34<sup>+</sup> cell-Derived Endothelial Cells Orchestrate Vascular and Immune Remodeling in the Transplanted Liver
May 1, 2026 · Journal of hepatology
Harnessing the oral microbiome in chronic liver disease: mechanisms, therapeutic modulation and translational frontiers
May 1, 2026 · Journal of hepatology
Uncovering immune dysfunction in ACLF: cellular mechanisms, molecular pathways, and therapeutic frontiers
Apr 26, 2026 · Journal of hepatology
Tim-3 facilitates dendritic cell ferroptosis and impairs anti-tumor immunity in steatohepatitis-related HCC
Apr 22, 2026 · Journal of hepatology
Single-nucleus profiling reveals hepatocyte identity and immune features associated with corticosteroid response in severe alcohol-related hepatitis
Apr 19, 2026 · Journal of hepatology
Fusobacterium nucleatum alleviates alcohol-associated liver disease through mannose-mediated elevation of Fbp1 and modulation of gut microbiota
More in Internal Medicine
View all →May 10, 2026 · JAMA
Digoxin in Patients With Symptomatic Rheumatic Heart Disease: A Randomized Clinical Trial
May 10, 2026 · European heart journal
Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in patients with heart failure: the DECISION trial
May 10, 2026 · Lancet (London, England)
Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication
May 10, 2026 · European heart journal
Renin-angiotensin-aldosterone system inhibition and haemocompatibility-related adverse events in patients with durable left ventricular assist device: the MOMENTUM-3 trial
May 10, 2026 · JAMA
Efficacy and Safety of Digitalis Glycosides in Heart Failure: A Meta-Analysis
May 10, 2026 · Lancet (London, England)
Impact of introducing RTS,S/AS01<sub>E</sub> malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
